Aharoni, Sharon http://orcid.org/0000-0001-7255-6276
Bistritzer, Jacob
Levine, Hagit
Sagi, Liora
Fattal-Valevski, Aviva
Ginzberg, Mira
Noyman, Iris
Cohen, Rony
Nevo, Yoram
Funding for this research was provided by:
Novartis Gene Therapies. Grant Number:PS2031
Article History
Received: 8 November 2021
Revised: 28 March 2022
Accepted: 8 April 2022
First Online: 27 April 2022
Competing interests
: SA has received clinical trial funding from AveXis/Novartis Gene Therapies and Biogen and has served on scientific advisory boards for AveXis/Novartis Gene Therapies. All other authors declare no competing interests.
: The study was approved by the Institutional Review Boards of the four Medical Centers. All analyses were performed on anonymized data. The approval for the study was provided by the local ethics committees, including at the Schneider Medical Center (RMC-0519-20); Tel Aviv Medical Center (TLV-873-18), Wolfson Medical Center (WOMC-0053-21), and Soroka Medical Center (SOR-0109-21).